These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 23096596)

  • 1. Tumour necrosis factor-alpha and matrix metalloproteinase-2 are expressed strongly in hidradenitis suppurativa.
    Mozeika E; Pilmane M; Nürnberg BM; Jemec GB
    Acta Derm Venereol; 2013 May; 93(3):301-4. PubMed ID: 23096596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hidradenitis suppurativa: the role of deficient cutaneous innate immunity.
    Dréno B; Khammari A; Brocard A; Moyse D; Blouin E; Guillet G; Léonard F; Knol AC
    Arch Dermatol; 2012 Feb; 148(2):182-6. PubMed ID: 22004878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment options in severe hidradenitis suppurativa].
    Mooij JE; van't Oost L; Leenarts MF; Mekkes JR
    Ned Tijdschr Geneeskd; 2011; 155():A1912. PubMed ID: 21426594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hedgehog pathway does not play a role in hidradenitis suppurativa pathogenesis.
    Mozeika E; Jemec GB; Nürnberg BM
    Exp Dermatol; 2011 Oct; 20(10):841-2. PubMed ID: 21824197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa.
    Emelianov VU; Bechara FG; Gläser R; Langan EA; Taungjaruwinai WM; Schröder JM; Meyer KC; Paus R
    Br J Dermatol; 2012 May; 166(5):1023-34. PubMed ID: 22136668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered innate and adaptive immune responses in patients with hidradenitis suppurativa.
    Giamarellos-Bourboulis EJ; Antonopoulou A; Petropoulou C; Mouktaroudi M; Spyridaki E; Baziaka F; Pelekanou A; Giamarellou H; Stavrianeas NG
    Br J Dermatol; 2007 Jan; 156(1):51-6. PubMed ID: 17199566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hidradenitis suppurativa: a disease of the absent sebaceous gland? Sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa.
    Kamp S; Fiehn AM; Stenderup K; Rosada C; Pakkenberg B; Kemp K; Dam TN; Jemec GB
    Br J Dermatol; 2011 May; 164(5):1017-22. PubMed ID: 21250966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hidradenitis suppurativa.
    Revuz J
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):985-98. PubMed ID: 19682181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β.
    van der Zee HH; de Ruiter L; van den Broecke DG; Dik WA; Laman JD; Prens EP
    Br J Dermatol; 2011 Jun; 164(6):1292-8. PubMed ID: 21332464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipidomics Profiling of Hidradenitis Suppurativa Skin Lesions Reveals Lipoxygenase Pathway Dysregulation and Accumulation of Proinflammatory Leukotriene B4.
    Penno CA; Jäger P; Laguerre C; Hasler F; Hofmann A; Gass SK; Wettstein-Ling B; Schaefer DJ; Avrameas A; Raulf F; Wieczorek G; Lehmann JCU; Loesche C; Roth L; Röhn TA
    J Invest Dermatol; 2020 Dec; 140(12):2421-2432.e10. PubMed ID: 32387270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipocalin-2 is expressed by activated granulocytes and keratinocytes in affected skin and reflects disease activity in acne inversa/hidradenitis suppurativa.
    Wolk K; Wenzel J; Tsaousi A; Witte-Händel E; Babel N; Zelenak C; Volk HD; Sterry W; Schneider-Burrus S; Sabat R
    Br J Dermatol; 2017 Nov; 177(5):1385-1393. PubMed ID: 28256718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid raft-enriched stem cell-like keratinocytes in the epidermis, hair follicles and sinus tracts in hidradenitis suppurativa.
    Gniadecki R; Jemec GB
    Exp Dermatol; 2004 Jun; 13(6):361-3. PubMed ID: 15186322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of innate defense antimicrobial peptides in hidradenitis suppurativa.
    Hofmann SC; Saborowski V; Lange S; Kern WV; Bruckner-Tuderman L; Rieg S
    J Am Acad Dermatol; 2012 Jun; 66(6):966-74. PubMed ID: 21982063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis and pharmacotherapy of Hidradenitis suppurativa.
    Nazary M; van der Zee HH; Prens EP; Folkerts G; Boer J
    Eur J Pharmacol; 2011 Dec; 672(1-3):1-8. PubMed ID: 21930119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum tumour necrosis factor-alpha in hidradenitis suppurativa patients: is there a basis for treatment with anti-tumour necrosis factor-alpha agents?
    Matusiak L; Bieniek A; Szepietowski JC
    Acta Derm Venereol; 2009 Nov; 89(6):601-3. PubMed ID: 19997690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hidradenitis suppurativa: the role of immune dysregulation.
    Kelly G; Sweeney CM; Tobin AM; Kirby B
    Int J Dermatol; 2014 Oct; 53(10):1186-96. PubMed ID: 24961484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hidradenitis Suppurativa Is Characterized by Dysregulation of the Th17:Treg Cell Axis, Which Is Corrected by Anti-TNF Therapy.
    Moran B; Sweeney CM; Hughes R; Malara A; Kirthi S; Tobin AM; Kirby B; Fletcher JM
    J Invest Dermatol; 2017 Nov; 137(11):2389-2395. PubMed ID: 28652108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hidradenitis suppurativa or acne inversa. A clinicopathological study of early lesions.
    Boer J; Weltevreden EF
    Br J Dermatol; 1996 Nov; 135(5):721-5. PubMed ID: 8977671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hidradenitis suppurativa: a review of cause and treatment.
    Yazdanyar S; Jemec GB
    Curr Opin Infect Dis; 2011 Apr; 24(2):118-23. PubMed ID: 21192260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in innate immunity and epithelial cell differentiation are the molecular pillars of hidradenitis suppurativa.
    Zouboulis CC; Nogueira da Costa A; Makrantonaki E; Hou XX; Almansouri D; Dudley JT; Edwards H; Readhead B; Balthasar O; Jemec GBE; Bonitsis NG; Nikolakis G; Trebing D; Zouboulis KC; Hossini AM
    J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):846-861. PubMed ID: 31838778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.